Compare ENVX & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENVX | ATEC |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2020 | 2006 |
| Metric | ENVX | ATEC |
|---|---|---|
| Price | $8.25 | $7.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $13.61 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 8.4M | 3.3M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.94 | 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | $31,821,000.00 | ★ $101,739,000.00 |
| Revenue This Year | $30.37 | $18.97 |
| Revenue Next Year | $238.73 | $16.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.91 | N/A |
| 52 Week Low | $4.67 | $6.82 |
| 52 Week High | $16.49 | $23.29 |
| Indicator | ENVX | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 65.49 | 41.60 |
| Support Level | $7.25 | $6.82 |
| Resistance Level | $8.79 | $8.42 |
| Average True Range (ATR) | 0.65 | 0.36 |
| MACD | 0.17 | 0.10 |
| Stochastic Oscillator | 78.59 | 48.26 |
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.